Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve

Summary

To compare the overall survival of thalidomide- and placebo-treated advanced HCC patients.

Timeline

Start

2003-02

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “slowly recruitment rate”

Drugs

Indications